Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Roberta Soares Faccion, Lidia Maria Magalhães Rezende, Sérgio de Oliveira Romano, Ricardo de Sá Bigni, Gelcio Luiz Quintella Mendes & Raquel Ciuvalschi Maia. (2012) Centroblastic Diffuse Large B Cell Lymphoma Displays Distinct Expression Pattern and Prognostic Role of Apoptosis Resistance Related Proteins. Cancer Investigation 30:5, pages 404-414.
Read now
Read now
Articles from other publishers (34)
Maciej Szydłowski, Filip Garbicz, Ewa Jabłońska, Patryk Górniak, Dorota Komar, Beata Pyrzyńska, Kamil Bojarczuk, Monika Prochorec-Sobieszek, Anna Szumera-Ciećkiewicz, Grzegorz Rymkiewicz, Magdalena Cybulska, Małgorzata Statkiewicz, Marta Gajewska, Michał Mikula, Aniela Gołas, Joanna Domagała, Magdalena Winiarska, Agnieszka Graczyk-Jarzynka, Emilia Białopiotrowicz, Anna Polak, Joanna Barankiewicz, Bartosz Puła, Michał Pawlak, Dominika Nowis, Jakub Golab, Andrea M. Tomirotti, Krzysztof Brzózka, Mariana Pacheco-Blanco, Kristyna Kupcova, Michael R. Green, Ondrej Havranek, Bjoern Chapuy & Przemysław Juszczyński. (2021) Inhibition of PIM Kinases in DLBCL Targets MYC Transcriptional Program and Augments the Efficacy of Anti-CD20 Antibodies. Cancer Research 81:23, pages 6029-6043.
Crossref
Crossref
Fereshteh Ashrafi, Sanaz Ahmadi Ghezeldasht & Mohadeseh Zarei Ghobadi. (2021) Identification of joint gene players implicated in the pathogenesis of HTLV-1 and BLV through a comprehensive system biology analysis. Microbial Pathogenesis 160, pages 105153.
Crossref
Crossref
Sankaranarayanan Kannan, Marisa J.L. Aitken, Shelley M. Herbrich, Leonard S. Golfman, Mandy G. Hall, Duncan H. Mak, Jared K. Burks, Guangchun Song, Marina Konopleva, Charles G. Mullighan, Joya Chandra & Patrick A. Zweidler-McKay. (2019) Antileukemia Effects of Notch-Mediated Inhibition of Oncogenic PLK1 in B-Cell Acute Lymphoblastic Leukemia. Molecular Cancer Therapeutics 18:9, pages 1615-1627.
Crossref
Crossref
Yuhua Feng, Jinguan Lin, Yiping Liu, Youhong Tang, Yangying Zhou & Meizuo Zhong. (2019)
Investigation of expressions of
PDK
1,
PLK
1 and c‐Myc in diffuse large B‐cell lymphoma
. International Journal of Experimental Pathology 100:1, pages 32-40.
Crossref
Crossref
Kyoung Il MinSilvia ParkSeung-Hwan ShinYong-Rim KwonHye-Joung KimYoo Jin Kim. (2019) Enhanced polo-like kinase 1 expression in myelodysplastic syndromes. Blood Research 54:2, pages 102.
Crossref
Crossref
Marina Kazantseva, Sunali Mehta, Ramona A. Eiholzer, Noelyn Hung, Anna Wiles, Tania L. Slatter & Antony W. Braithwaite. (2018) A mouse model of the Δ133p53 isoform: roles in cancer progression and inflammation. Mammalian Genome 29:11-12, pages 831-842.
Crossref
Crossref
Kristian W Pajtler, Natalie Sadowski, Sandra Ackermann, Kristina Althoff, Kerstin Schönbeck, Katharina Batzke, Simonäfers Sch, Andrea Odersky, Lukas Heukamp, Kathy Astrahantseff, Annette Künkele, Hedwig E Deubzer, Alexander Schramm, Annikaüssel Spr, Theresa Thor, Sven Lindner, Angelika Eggert, Matthias Fischer & Johannes H Schulte. (2016) The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma models. Oncotarget 8:4, pages 6730-6741.
Crossref
Crossref
Deming Ou, Ying Wu, Jun Liu, Xiaomei Lao, Sien Zhang & Guiqing Liao. (2016) miRNA-335 and miRNA-182 affect the occurrence of tongue squamous cell carcinoma by targeting survivin. Oncology Letters 12:4, pages 2531-2537.
Crossref
Crossref
Carsten Berges, Manik Chatterjee, Max S. Topp & Hermann Einsele. (2016) Targeting polo-like kinase 1 suppresses essential functions of alloreactive T cells. Immunologic Research 64:3, pages 687-698.
Crossref
Crossref
Chetasi Talati, Elizabeth A. Griffiths, Meir Wetzler & Eunice S. Wang. (2016) Polo-like kinase inhibitors in hematologic malignancies. Critical Reviews in Oncology/Hematology 98, pages 200-210.
Crossref
Crossref
V. S. Gil, G. Bhagat, L. Howell, J. Zhang, C. H. Kim, S. Stengel, F. Vega, A. Zelent & K. Petrie. (2016) Deregulated expression of HDAC9 in B-cells promotes development of lymphoproliferative disease and lymphoma. Disease Models & Mechanisms.
Crossref
Crossref
Haitham Gabr, Juan Carlos Rivera-Mulia, David M. Gilbert & Tamer Kahveci. (2015) Computing interaction probabilities in signaling networks. EURASIP Journal on Bioinformatics and Systems Biology 2015:1.
Crossref
Crossref
Ya Zhang, Jianhong Wang, Xiaohui Sui, Ying Li, Kang Lu, Xiaosheng Fang, Yujie Jiang & Xin Wang. (2015) Prognostic and Clinicopathological Value of Survivin in Diffuse Large B-cell Lymphoma. Medicine 94:36, pages e1432.
Crossref
Crossref
Nazma MalikStefan VollmerSambit Kumar NandaMarta Lopez-PelaezAlan PrescottNathanael GrayPhilip Cohen. (2015) Suppression of interferon β gene transcription by inhibitors of bromodomain and extra-terminal (BET) family members. Biochemical Journal 468:3, pages 363-372.
Crossref
Crossref
Joseph M. Brandwein. (2015) Targeting polo-like kinase 1 in acute myeloid leukemia. Therapeutic Advances in Hematology 6:2, pages 80-87.
Crossref
Crossref
Prithviraj Bose, Yun Dai & Steven Grant. (2014) Histone deacetylase inhibitor (HDACI) mechanisms of action: Emerging insights. Pharmacology & Therapeutics 143:3, pages 323-336.
Crossref
Crossref
Ahmed M. L. Bedewy, Maha M. Adel Elgammal, Magdy M. L. Bedewy & Shereen M. EL-Maghraby. (2013) Assessing DcR3 expression in relation to survivin and other prognostic factors in B cell non-Hodgkin’s lymphoma. Annals of Hematology 92:10, pages 1359-1367.
Crossref
Crossref
Harriet E Sandison, Suzanne Usher, Ehsan G Karimiani, Garry Ashton, Lia P Menasce, John A Radford, Kim Linton & Richard J Byers. (2013) PLK1 and YY1 interaction in follicular lymphoma is associated with unfavourable outcome. Journal of Clinical Pathology 66:9, pages 764-767.
Crossref
Crossref
Girija Dasmahapatra, Hiral Patel, Tri Nguyen, Elisa Attkisson & Steven Grant. (2013)
PLK1 Inhibitors Synergistically Potentiate HDAC Inhibitor Lethality in Imatinib Mesylate–Sensitive or –Resistant BCR/ABL+ Leukemia Cells
In Vitro
and
In Vivo
. Clinical Cancer Research 19:2, pages 404-414.
Crossref
Crossref
Zhisen Shen, Guowen Zhan, Dong Ye, Yuan Ren, Lixin Cheng, Zhenhua Wu & Junming Guo. (2012) MicroRNA-34a affects the occurrence of laryngeal squamous cell carcinoma by targeting the antiapoptotic gene survivin. Medical Oncology 29:4, pages 2473-2480.
Crossref
Crossref
Judy Quiju Shi, Kerri Lasky, Vaishali Shinde, Bradley Stringer, Mark G. Qian, Debra Liao, Ray Liu, Denise Driscoll, Michelle Tighe Nestor, Benjamin S. Amidon, Youlan Rao, Matt O. Duffey, Mark G. Manfredi, Tricia J. Vos, Natalie D' Amore & Marc L. Hyer. (2012)
MLN0905, a Small-Molecule
PLK1
Inhibitor, Induces Antitumor Responses in Human Models of Diffuse Large B-cell Lymphoma
. Molecular Cancer Therapeutics 11:9, pages 2045-2053.
Crossref
Crossref
Ronan J Kelly, Ariel Lopez-Chavez, Deborah Citrin, John E Janik & John C Morris. (2011) Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin. Molecular Cancer 10:1.
Crossref
Crossref
Zdravko Mitrović, Ivana Ilić, Igor Aurer, Sandra Bašić Kinda, Ivo Radman, Snježana Dotlić, Radmila Ajduković & Boris Labar. (2010) Prognostic Significance of Survivin and Caspase-3 Immunohistochemical Expression in Patients with Diffuse Large B-cell Lymphoma Treated with Rituximab and CHOP. Pathology & Oncology Research 17:2, pages 243-247.
Crossref
Crossref
Zhisen Shen, Zhen Jiang, Dong Ye, Bingxiu Xiao, Xingang Zhang & Junming Guo. (2010) Growth inhibitory effects of DJ-1-small interfering RNA on laryngeal carcinoma Hep-2 cells. Medical Oncology 28:2, pages 601-607.
Crossref
Crossref
Tania L. SlatterNoelyn HungHamish Campbell, Carina Rubio, Reena Mehta, Prudence RenshawGail WilliamsMichelle Wilson, Afra Engelmann, Aaron JeffsJanice A. RoydsMargaret A. Baird & Antony W. Braithwaite. (2011) Hyperproliferation, cancer, and inflammation in mice expressing a Δ133p53-like isoform. Blood 117:19, pages 5166-5177.
Crossref
Crossref
N. Stutz, M. Nihal & G.S. Wood. (2011) Polo-like kinase 1 (Plk1) in cutaneous T-cell lymphoma. British Journal of Dermatology 164:4, pages 814-821.
Crossref
Crossref
Z Shen, D Ye, X Zhang, Z Jiang, B Xiao & J Guo. (2010)
Inhibitory effect of
HuR
gene small interfering RNA segment on laryngeal carcinoma Hep-2 cell growth
. The Journal of Laryngology & Otology 124:11, pages 1183-1189.
Crossref
Crossref
Klaus Strebhardt. (2010) Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy. Nature Reviews Drug Discovery 9:8, pages 643-660.
Crossref
Crossref
J. Wimmershoff, A. Polkinghorne, P. Grest, B. Schade, T. Marchal, S.M. Keller & F. Guscetti. (2010) Immunohistochemical Detection of Survivin in Canine Lymphoma. Journal of Comparative Pathology 142:4, pages 311-322.
Crossref
Crossref
Takayuki Ikezoe, Tamotsu Takeuchi, Jing Yang, Yoshihiro Adachi, Chie Nishioka, Mutsuo Furihata, H Phillip Koeffler & Akihito Yokoyama. (2009) Analysis of Aurora B kinase in non-Hodgkin lymphoma. Laboratory Investigation 89:12, pages 1364-1373.
Crossref
Crossref
Semra Paydas, Melek Ergin, Gulsah Seydaoglu, Seyda Erdogan & Sinan Yavuz. (2009) Pronostic significance of angiogenic/lymphangiogenic, anti-apoptotic, inflammatory and viral factors in 88 cases with diffuse large B cell lymphoma and review of the literature. Leukemia Research 33:12, pages 1627-1635.
Crossref
Crossref
Annelies G. Renner, Cédric Dos SantosChristian Recher, Christian Bailly, Laurent Créancier, Anna Kruczynski, Bernard Payrastre & Stéphane Manenti. (2009) Polo-like kinase 1 is overexpressed in acute myeloid leukemia and its inhibition preferentially targets the proliferation of leukemic cells. Blood 114:3, pages 659-662.
Crossref
Crossref
David Olmos, Charles Swanton & Johann de Bono. (2008) Targeting Polo-Like Kinase: Learning Too Little Too Late?. Journal of Clinical Oncology 26:34, pages 5497-5499.
Crossref
Crossref
Rong Luo, Weijia Kong & Yanjun Wang. (2008) Elevated expressions of Survivin and VEGF proteins are strong independent predictors of survival in squamous carcinoma of larynx. The Chinese-German Journal of Clinical Oncology 7:11, pages 661-665.
Crossref
Crossref